American journal of surgery
-
Randomized Controlled Trial Multicenter Study Comparative Study
Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.
This open-label study compared oral or intravenous linezolid with intravenous vancomycin for treatment of complicated skin and soft-tissue infections (cSSTIs) caused by methicillin-resistant Staphylococcus aureus (MRSA). ⋯ Linezolid is an effective alternative to vancomycin for the treatment of cSSTI caused by MRSA.